Targeting lipid signalling receptors to promote remyelination in multiple sclerosis [ 1/1/2021 - 12/31/2024 ]

Research Grant

Brief description Multiple sclerosis is caused by the immune system mistakenly attacking and depleting myelin, the fatty substance that insulates neurons in our nervous system. To improve MS therapy and open up the possibility for functional recovery, we must develop drugs that protect and regenerate myelin. We will define how the loss of certain key biochemical signals promotes myelin loss in MS, and how drugs that restore those signals may be used to protect and regenerate myelin in people with the disease.

Funding Amount $925,907

Funding Scheme Ideas Grants

Chief Investigator A/Pr Anthony Don

Notes Ideas Grants